Literature DB >> 22414314

Development and evaluation of a modified Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease to distinguish functional dyspepsia from non-erosive reflux disease.

Motoyasu Kusano1, Hiroko Hosaka, Akiyo Kawada, Shikou Kuribayashi, Yasuyuki Shimoyama, Osamu Kawamura, Fumitaka Moki.   

Abstract

BACKGROUND AND AIM: The Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease (FSSG) is the standard questionnaire used in Japan for the diagnosis of gastroesophageal reflux disease (GERD) and assessment of the response to treatment. We modified the FSSG in order to assess dyspepsia symptoms, and evaluated the modified questionnaire.
METHODS: We modified the FSSG by adding two questions on interdigestive and postprandial epigastric pain. We then assessed the modified FSSG with 100 new untreated symptomatic patients presenting to hospital and in 200 subjects undergoing health checks. Endoscopic assessment of the esophagogastric junction was performed according to the modified Los Angeles classification with addition of Grade N (normal appearance) and Grade M (minimal change). Endoscopic images were assessed by five experienced endoscopists blinded to the questionnaire results.
RESULTS: The 100 new patients included 16 with erosive GERD (>Grade A), 12 with peptic ulcer, and two with gastric cancer. Among the 70 patients with no evidence of organic disease, the modified FSSG diagnosed functional dyspepsia (FD) in 41 and non-erosive gastric disease (NERD) in 29. A significant difference was seen in the dyspepsia score between patients with FD and NERD. Subjects with endoscopic GERD undergoing health checks had significantly higher scores for all symptoms, reflux symptoms, and dyspeptic symptoms on the modified FSSG.
CONCLUSION: The modified FSSG can clearly distinguish FD from NERD, and is useful for the assessment of dyspeptic symptoms.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22414314     DOI: 10.1111/j.1440-1746.2012.07121.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  11 in total

1.  Therapeutic strategy for the patients with coexisting gastroesophageal reflux disease and postprandial distress syndrome of functional dyspepsia.

Authors:  Kimio Isshi; Hiroto Furuhashi; Koji Nakada
Journal:  JGH Open       Date:  2020-02-03

2.  More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.

Authors:  Motoyasu Kusano; Hiroko Hosaka; Osamu Kawamura; Akiyo Kawada; Shiko Kuribayashi; Yasuyuki Shimoyama; Hidetoshi Yasuoka; Masafumi Mizuide; Taku Tomizawa; Toshihiko Sagawa; Ken Sato; Masanobu Yamada
Journal:  J Gastroenterol       Date:  2014-06-12       Impact factor: 7.527

3.  New endoscopic method for gastric hypersensitivity testing: Pilot study.

Authors:  Eri Momma; Mai Koeda; Tomohide Tanabe; Saori Kanai; Yoshimasa Hoshikawa; Shintaro Hoshino; Noriyuki Kawami; Mitsuru Kaise; Katsuhiko Iwakiri
Journal:  JGH Open       Date:  2021-04-07

4.  Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study.

Authors:  Tomoari Kamada; Motonori Sato; Tadashi Tokutomi; Tetsuo Watanabe; Takahisa Murao; Hiroshi Matsumoto; Noriaki Manabe; Masanori Ito; Shinji Tanaka; Kazuhiko Inoue; Akiko Shiotani; Takashi Akiyama; Jiro Hata; Ken Haruma
Journal:  Biomed Res Int       Date:  2015-04-28       Impact factor: 3.411

5.  Impact of improvement of sleep disturbance on symptoms and quality of life in patients with functional dyspepsia.

Authors:  Fumihiko Nakamura; Shiko Kuribayashi; Fumio Tanaka; Noriyuki Kawami; Yasuhiro Fujiwara; Katsuhiko Iwakiri; Motoyasu Kusano; Toshio Uraoka
Journal:  BMC Gastroenterol       Date:  2021-02-18       Impact factor: 3.067

6.  The effects of concomitant GERD, dyspepsia, and rhinosinusitis on asthma symptoms and FeNO in asthmatic patients taking controller medications.

Authors:  Tamotsu Ishizuka; Takeshi Hisada; Yosuke Kamide; Haruka Aoki; Kaori Seki; Chisato Honjo; Hiroyuki Sakai; Maiko Kadowaki; Yukihiro Umeda; Miwa Morikawa; Masaki Anzai; Shingo Ameshima; Takeshi Ishizaki; Kunio Dobashi; Masanobu Yamada; Motoyasu Kusano
Journal:  J Asthma Allergy       Date:  2014-09-05

7.  Helicobacter pylori infection status had no influence on upper gastrointestinal symptoms: a cross-sectional analysis of 3,005 Japanese subjects without upper gastrointestinal lesions undergoing medical health checkups.

Authors:  Tomomi Yoshioka; Eri Takeshita; Yasuhisa Sakata; Megumi Hara; Kayo Akutagawa; Natsuko Sakata; Hiroyoshi Endo; Takashi Ohyama; Keiji Matsunaga; Yuichiro Tanaka; Shinpei Shirai; Yoichiro Ito; Nanae Tsuruoka; Ryuichi Iwakiri; Motoyasu Kusano; Kazuma Fujimoto
Journal:  Esophagus       Date:  2017-03-15       Impact factor: 4.230

8.  Efficacy and Safety Profile of Z-215 (Azeloprazole Sodium), a Proton Pump Inhibitor, Compared with Rabeprazole Sodium in Patients with Reflux Esophagitis: A Phase II, Multicenter, Randomized, Double-Blind, Comparative Study.

Authors:  Yoshikazu Kinoshita; Motoyasu Kusano; Katsuhiko Iwakiri; Mitsuhiro Fujishiro; Naoto Tachikawa; Ken Haruma
Journal:  Curr Ther Res Clin Exp       Date:  2018-03-22

9.  Helicobacter pylori eradication improves the quality of life regardless of the treatment outcome: A multicenter prospective cohort study.

Authors:  Hiroki Taguchi; Shuji Kanmura; Takuro Maeda; Hiromichi Iwaya; Shiho Arima; Fumisato Sasaki; Yuichirou Nasu; Shiroh Tanoue; Shinichi Hashimoto; Akio Ido
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

Review 10.  Evidence-based clinical practice guidelines for functional dyspepsia 2021.

Authors:  Hiroto Miwa; Akihito Nagahara; Akihiro Asakawa; Makoto Arai; Tadayuki Oshima; Kunio Kasugai; Kazuhiro Kamada; Hidekazu Suzuki; Fumio Tanaka; Kazunari Tominaga; Seiji Futagami; Mariko Hojo; Hiroshi Mihara; Kazuhide Higuchi; Motoyasu Kusano; Tomiyasu Arisawa; Mototsugu Kato; Takashi Joh; Satoshi Mochida; Nobuyuki Enomoto; Tooru Shimosegawa; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2022-01-21       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.